Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
Randomized Phase 2 Study of DKN-01 Plus FOLFIRI/FOLFOX and Bevacizumab Versus FOLFIRI/FOLFOX and Bevacizumab as Second-line Treatment of Advanced Colorectal Cancer (DeFianCe)
Sponsored by Leap Therapeutics, Inc.
Active
$568.2K Funding
7 People
External
Related Topics
colorectal cancer,
treatment,
clinical trial,
dkn-01,
chemotherapy
People
Hina Arif Tiwari
Co-Investigator (COI)
Pathology and Lab Medicine
﹒Professor
Diana Dawson
(CD)
Cancer Center Division
﹒Research Compliance Administrator II
Junaid Arshad
Co-Investigator (COI)
Medicine
﹒Assistant Professor, Medicine - (Clinical Scholar Track)
Rachna Shroff
Co-Investigator (COI)
Medicine
﹒Professor
Umbreen Rozell
Co-Investigator (COI)
Medicine
﹒Assistant Clinical Professor, Medicine - (Clinical Series Track)
Gustavo Cornejo
(CD)
Senior VP Health Sciences
﹒Research Compliance Administrator III
Brianna Denton
(CD)
Cancer Center Division
﹒Research Compliance Manager I
